Stereotactic radiotherapy of central nervous system and head and neck lesions, using a conformal intensity-modulated radiotherapy system (Peacock™ system)

被引:5
作者
Ammirati, M
Bernardo, A
Ramsinghani, N
Yakoob, R
Al-Ghazi, M
Kuo, J
Ammirati, G
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Neurosurg, Camden, NJ 08103 USA
[2] Univ Calif Irvine, Dept Radiat Oncol, Irvine, CA USA
来源
SKULL BASE-AN INTERDISCIPLINARY APPROACH | 2001年 / 11卷 / 02期
关键词
intensity-modulated radiotherapy; intracranial lesions; linear accelerator; stereotactic radiotherapy;
D O I
10.1055/s-2001-14435
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The objective of this article is to evaluate single-fraction or fractionated stereotactic radiotherapy of central nervous system (CNS) and head and neck lesions using intensity-modulated radiotherapy (IMRT) with a commercially available system (Peacock(TM), Nomos Corporation, Sewickley, PA). This system allows tomotherapeutic delivery of intensity-modulated radiation, that is, the slice-by-slice treatment of the volume of interest with an intensity-modulated beam, making the delivery of highly conformal radiation to the target possible in both single or multiple fractions mode. During an 18-month period, 43 (21 males and 22 females) patients were treated, using a removable cranial screw-fixation device. Ages ranged from 10 to 77 years (mean, 52.2; median, 53.5). Intra- and extra-axial lesions, including head and neck malignancies and spine metastases, were treated. Clinical target volume ranged from 0.77 to 195 cm(3) (mean, 47.8; median, 29.90). The dose distribution was normalized to the maximum and was prescribed, in most cases, at the 80% or 90% isodose line (range, 65 to 96%; median, 85%; mean, 83.4%) and ranged from 14 to 80 Gy (mean, 48; median, 50). The number of fractions ranged from 1 to 40 (mean, 23; median, 25). In all but one patient, 90% of the prescription isodose line covered 100% of the clinical target volume. The heterogeneity index (the ratio between the maximum radiation dose and the prescribed dose) ranged between 1.0 and 1.50, whereas the conformity index (the ratio between the volume encompassed by the prescription isodose line and the clinical target volume) ranged between 1.0 and 4.5. There were no complications related to the radiation treatment. With a median followup of 6 months, more than 70% of our patients showed decreased lesion size. Stereotactic IMRT of CNS and head and neck lesions can be delivered safely and accurately. The Peacock system delivers stereotactic radiation in single or multiple fractions and has no volume limitations. It has been used to treat intracranial, head and neck, and spinal lesions. The option of fractionation, the lack of volume constraint, and the capability of treating intracranial, head and neck, and spinal pathology make stereotactic IMRT a valuable adjunct to established stereotactic radiotherapy systems delivering convergent-beam irradiation using the Linac or Gamma Knife. In a clinical setting that offers Linac, Gamma Knife radiosurgery, and conformal stereotactic radiotherapy, the latter may have advantages for treating large (> 25-cm(3)) and irregular lesions, especially when fractionation is considered useful.
引用
收藏
页码:109 / 119
页数:11
相关论文
共 13 条
[1]  
[Anonymous], 1993, 50 ICRU
[2]  
CAROL MP, 1997, THEORY PRACTICE INTE, P17
[3]   TOLERANCE OF NORMAL TISSUE TO THERAPEUTIC IRRADIATION [J].
EMAMI, B ;
LYMAN, J ;
BROWN, A ;
COIA, L ;
GOITEIN, M ;
MUNZENRIDER, JE ;
SHANK, B ;
SOLIN, LJ ;
WESSON, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :109-122
[4]  
LARSON DA, 1998, TXB RAD ONCOLOGY, P391
[5]   VARIABLES ASSOCIATED WITH THE DEVELOPMENT OF COMPLICATIONS FROM RADIOSURGERY OF INTRACRANIAL TUMORS [J].
NEDZI, LA ;
KOOY, H ;
ALEXANDER, E ;
GELMAN, RS ;
LOEFFLER, JS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (03) :591-599
[6]  
PEREZ CA, 1998, PRINCIPLES PRACTICE, P13
[7]  
PEREZ CA, 1998, PRINCIPLES PRACTICE, P23
[8]   STEREOTAXIC RADIOSURGERY - A REVIEW AND COMPARISON OF METHODS [J].
PHILLIPS, MH ;
STELZER, KJ ;
GRIFFIN, TW ;
MAYBERG, MR ;
WINN, HR .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (05) :1085-1099
[9]   RADIATION-THERAPY ONCOLOGY GROUP - RADIOSURGERY QUALITY ASSURANCE GUIDELINES [J].
SHAW, E ;
KLINE, R ;
GILLIN, M ;
SOUHAMI, L ;
HIRSCHFELD, A ;
DINAPOLI, R ;
MARTIN, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (05) :1231-1239
[10]  
SHOSHAN Y, 2000, LINAC GAMMA KNIFE RA, P57